+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vital Proteins for Biomanufacturing Market - Global Forecast 2026-2030- Product Image
Vital Proteins for Biomanufacturing Market - Global Forecast 2026-2030- Product Image
New

Vital Proteins for Biomanufacturing Market - Global Forecast 2026-2030

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5889105
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vital proteins for biomanufacturing market is advancing rapidly, bringing new pressures and opportunities for operational and procurement leaders. Innovations in protein expression, evolving sourcing models, and new regulatory dynamics are reshaping strategies in this sector, impacting how organizations source and manage critical protein inputs for cutting-edge bioprocessing applications.

Market Snapshot: Global Vital Proteins for Biomanufacturing

The Vital Proteins for Biomanufacturing Market expanded from USD 56.52 billion in 2024 to USD 61.47 billion in 2025 and is projected to reach USD 94.81 billion by 2030 at a CAGR of 9.00%. This growth is underpinned by increased demand for premium protein inputs and a push toward more resilient, adaptable supply chain strategies. Organizations across the sector are investing in new bioproduction technologies, and shifting procurement priorities to ensure the stable supply of complex vital proteins. As competition grows, supply chain agility and regulatory preparedness are now central differentiators for senior executives.

Scope & Segmentation of the Vital Proteins for Biomanufacturing Market

This report provides a granular breakdown of the vital proteins for biomanufacturing market, enabling leadership teams to align sourcing and partnership strategies with evolving industry and regulatory requirements. The segmentation focuses on the following:

  • Product Types: Includes Affinity Ligands & Binding Proteins such as Protein A, Protein G, Protein L, and Streptavidin/Avidin. Carrier Proteins (Albumins, Ferritin, Transferrins), Chaperones & Folding Aids (for efficient protein folding), and a broad spectrum of Enzymes for critical bioprocesses. Also covers Extracellular Matrix & Coatings (e.g., Collagens, Laminins), Growth Factors & Cytokines pivotal for bioproduction, and advanced Serum Replacements supporting defined manufacturing conditions.
  • Source Types: Spans Animal-Derived and Plant-Based sources, Mammalian and Microbial Expression Systems, as well as advanced Cell-Free and Recombinant options, each with distinct scalability and regulatory characteristics.
  • Application Areas: Ranges from Animal Nutrition (e.g., aquaculture, livestock), Cosmetics (hair, skin, oral care), Medical Devices (implants, wound dressings), Nutraceuticals (for sports, skin, joint health), to Pharmaceuticals (drug delivery, tissue engineering, wound repair).
  • End-Users: Differentiates between Academic & Research Institutions, Contract Research Organizations (CROs), and Pharmaceutical & Biotechnology Companies, each requiring tailored quality and validation approaches.
  • Distribution Pathways: Incorporates both Direct Sales and established Distributor channels, offering procurement flexibility and risk diversification.
  • Region Coverage: Considers the Americas, Europe Middle East & Africa, and Asia-Pacific, with emphasis on regional manufacturing hubs, policy frameworks, and influencing supply chain and partnership decisions.

Vital Proteins for Biomanufacturing: Key Takeaways

  • Vital proteins have evolved from simple reagents to integral bioprocess inputs, increasing their impact across upstream and downstream operations.
  • Maturing production technologies, especially in microbial and cell-free systems, drive faster scale-ups and more consistent performance, supporting reliable technology transfer between regions and facilities.
  • Supplier assessment now prioritizes traceable sourcing, comprehensive quality documentation, and validated analytics. Regulatory stakeholders are intensifying scrutiny of raw materials and impurity control requirements.
  • Regional supply clusters create momentum for localized sourcing; however, differences in local regulations and workforce expertise require flexible, adaptive sourcing frameworks.
  • Collaboration between suppliers and contract manufacturers is central for supporting integrated workflows and reducing risk concentrations across the value chain.
  • Implementation of digital traceability and analytics tools in supply chain systems enhances visibility, supporting proactive scenario planning and lowering overall operational risk.

Tariff Impact on Sourcing and Procurement Operations

Recent tariff changes, particularly in the United States, are adding complexity to upstream protein sourcing and procurement strategies. Organizations are responding by diversifying sourcing geography, engaging both domestic and multi-jurisdictional partners, and increasing reliance on local contract manufacturing. Transparent landed-cost models have become essential for compliance and cost control, encouraging more robust engagement strategies with regional suppliers to minimize exposure to tariff fluctuations.

Methodology & Data Sources

This report relies on a mixed-methods research framework, combining insights from interviews with supply chain and regulatory professionals, due diligence on key suppliers, and an in-depth review of primary scientific and regulatory literature. This methodology supports reliable, actionable findings that address practical challenges faced by sourcing and procurement leaders.

Why This Report Matters to Your Sourcing Strategy

  • Allows procurement and operations leaders to align frameworks to emerging quality, regulatory, and supply chain expectations.
  • Offers holistic segmentation of the vital proteins for biomanufacturing market, giving teams the evidence to refine supplier selection and product portfolio planning.
  • Equips organizations with intelligence to adapt sourcing strategies, risk management processes, and partnership models for sustained resilience and competitive growth.

Conclusion

Competitive advantage in the vital proteins for biomanufacturing market relies on strategic sourcing, rigorous quality management, and targeted investments in technology and regional capabilities. Organizations that emphasize data-driven supplier evaluation and collaborative partnerships will foster stability and operational success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2024
3.5. FPNV Positioning Matrix, 2024
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Vital Proteins for Biomanufacturing Market, by Product Type
8.1. Affinity Ligands & Binding Proteins
8.1.1. Protein A
8.1.2. Protein G
8.1.3. Protein L
8.1.4. Streptavidin/Avidin
8.2. Carrier Proteins
8.2.1. Albumins
8.2.2. Ferritin & Others
8.2.3. Transferrins
8.3. Chaperones & Folding Aids
8.3.1. Chaperonins
8.3.2. Protein Disulfide Isomerase
8.4. Enzymes
8.4.1. Glycosidases
8.4.2. Kinases
8.4.3. Ligases
8.4.4. Nucleases
8.4.5. Polymerases
8.4.6. Proteases
8.5. Extracellular Matrix & Coatings
8.5.1. Collagens
8.5.2. Fibronectins
8.5.3. Laminins
8.5.4. Vitronectin
8.6. Growth Factors & Cytokines
8.6.1. EGF Family
8.6.2. FGF Family
8.6.3. IGF/Insulin Family
8.6.4. Interleukins & Chemokines
8.6.5. TGF-Beta/BMP Family
8.6.6. VEGF/PDGF Family
8.7. Serum Replacements
8.7.1. Defined Protein Mixes
8.7.2. Recombinant Albumin Blends
9. Vital Proteins for Biomanufacturing Market, by Source
9.1. Animal-Derived
9.2. Cell-Free Systems
9.3. Mammalian Cell Systems
9.4. Microbial Expression Systems
9.5. Plant-Based
9.6. Recombinant
10. Vital Proteins for Biomanufacturing Market, by Application
10.1. Animal Nutrition
10.1.1. Aquaculture Feed
10.1.2. Livestock Feed
10.1.3. Pet Food
10.2. Cosmetics
10.2.1. Hair Care
10.2.2. Oral Care
10.2.3. Skin Care
10.3. Medical Devices
10.3.1. Scaffold Materials
10.3.2. Surgical Implants
10.3.3. Wound Dressings
10.4. Nutraceuticals
10.4.1. Bone Health
10.4.2. Joint Health
10.4.3. Skin Health
10.4.4. Sports Nutrition
10.5. Pharmaceuticals
10.5.1. Drug Delivery
10.5.2. Tissue Engineering
10.5.3. Wound Healing
11. Vital Proteins for Biomanufacturing Market, by End-Use
11.1. Academic & Research Institutions
11.2. Contract Research Organizations (CROs)
11.3. Pharmaceutical & Biotechnology Companies
12. Vital Proteins for Biomanufacturing Market, by Distribution Channel
12.1. Direct Sales
12.2. Distributors
13. Vital Proteins for Biomanufacturing Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Vital Proteins for Biomanufacturing Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Vital Proteins for Biomanufacturing Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Vital Proteins for Biomanufacturing Market
17. China Vital Proteins for Biomanufacturing Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2024
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2024
18.3. Product Portfolio Analysis, 2024
18.4. Benchmarking Analysis, 2024
18.5. Danaher Corporation
18.6. Darling Ingredients Inc.
18.7. Gelita AG
18.8. Humabiologics, Inc
18.9. Lonza Group AG
18.10. Merck KGaA
18.11. Nitta Gelatin, Inc.
18.12. Thermo Fisher Scientific Inc.
18.13. Weishardt International
List of Figures
FIGURE 1. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 2. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 3. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 4. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 13. CHINA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
List of Tables
TABLE 1. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 2. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 3. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AFFINITY LIGANDS & BINDING PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AFFINITY LIGANDS & BINDING PROTEINS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AFFINITY LIGANDS & BINDING PROTEINS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AFFINITY LIGANDS & BINDING PROTEINS, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN A, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN A, BY GROUP, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN A, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN G, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN G, BY GROUP, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN G, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN L, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN L, BY GROUP, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN L, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STREPTAVIDIN/AVIDIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STREPTAVIDIN/AVIDIN, BY GROUP, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY STREPTAVIDIN/AVIDIN, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CARRIER PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CARRIER PROTEINS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CARRIER PROTEINS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CARRIER PROTEINS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ALBUMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ALBUMINS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ALBUMINS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FERRITIN & OTHERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FERRITIN & OTHERS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FERRITIN & OTHERS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSFERRINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSFERRINS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TRANSFERRINS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONES & FOLDING AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONES & FOLDING AIDS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONES & FOLDING AIDS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONES & FOLDING AIDS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONINS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONINS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN DISULFIDE ISOMERASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN DISULFIDE ISOMERASE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEIN DISULFIDE ISOMERASE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GLYCOSIDASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GLYCOSIDASES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GLYCOSIDASES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY KINASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY KINASES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY KINASES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LIGASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LIGASES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LIGASES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUCLEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUCLEASES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUCLEASES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY POLYMERASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY POLYMERASES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY POLYMERASES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEASES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PROTEASES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXTRACELLULAR MATRIX & COATINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXTRACELLULAR MATRIX & COATINGS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXTRACELLULAR MATRIX & COATINGS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXTRACELLULAR MATRIX & COATINGS, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COLLAGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COLLAGENS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COLLAGENS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FIBRONECTINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FIBRONECTINS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FIBRONECTINS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LAMININS, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LAMININS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LAMININS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VITRONECTIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VITRONECTIN, BY GROUP, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VITRONECTIN, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EGF FAMILY, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EGF FAMILY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EGF FAMILY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FGF FAMILY, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FGF FAMILY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY FGF FAMILY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY IGF/INSULIN FAMILY, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY IGF/INSULIN FAMILY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY IGF/INSULIN FAMILY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERLEUKINS & CHEMOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERLEUKINS & CHEMOKINES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY INTERLEUKINS & CHEMOKINES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TGF-BETA/BMP FAMILY, BY REGION, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TGF-BETA/BMP FAMILY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TGF-BETA/BMP FAMILY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VEGF/PDGF FAMILY, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VEGF/PDGF FAMILY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY VEGF/PDGF FAMILY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SERUM REPLACEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SERUM REPLACEMENTS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SERUM REPLACEMENTS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SERUM REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DEFINED PROTEIN MIXES, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DEFINED PROTEIN MIXES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DEFINED PROTEIN MIXES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT ALBUMIN BLENDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT ALBUMIN BLENDS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT ALBUMIN BLENDS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL-DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 114. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL-DERIVED, BY GROUP, 2018-2030 (USD MILLION)
TABLE 115. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL-DERIVED, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 117. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 118. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 119. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MAMMALIAN CELL SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 120. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MAMMALIAN CELL SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 121. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MAMMALIAN CELL SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 122. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MICROBIAL EXPRESSION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 123. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MICROBIAL EXPRESSION SYSTEMS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 124. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 126. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PLANT-BASED, BY GROUP, 2018-2030 (USD MILLION)
TABLE 127. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PLANT-BASED, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 128. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
TABLE 129. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2030 (USD MILLION)
TABLE 130. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 133. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL NUTRITION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 134. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL NUTRITION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 136. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 137. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AQUACULTURE FEED, BY GROUP, 2018-2030 (USD MILLION)
TABLE 138. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AQUACULTURE FEED, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 139. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 140. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LIVESTOCK FEED, BY GROUP, 2018-2030 (USD MILLION)
TABLE 141. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY LIVESTOCK FEED, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 142. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PET FOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 143. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PET FOOD, BY GROUP, 2018-2030 (USD MILLION)
TABLE 144. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PET FOOD, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 145. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 146. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 147. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 148. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 149. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY HAIR CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 150. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY HAIR CARE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 151. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY HAIR CARE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 152. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ORAL CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 153. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ORAL CARE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 154. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ORAL CARE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 155. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 156. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2030 (USD MILLION)
TABLE 157. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 158. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 159. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 160. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 161. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 162. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 163. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SCAFFOLD MATERIALS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 164. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SCAFFOLD MATERIALS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 165. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SURGICAL IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 166. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SURGICAL IMPLANTS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 167. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SURGICAL IMPLANTS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 168. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY WOUND DRESSINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 169. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY WOUND DRESSINGS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 170. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY WOUND DRESSINGS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 171. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 172. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUTRACEUTICALS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 173. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUTRACEUTICALS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 175. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BONE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 176. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BONE HEALTH, BY GROUP, 2018-2030 (USD MILLION)
TABLE 177. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY BONE HEALTH, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 178. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY JOINT HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 179. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY JOINT HEALTH, BY GROUP, 2018-2030 (USD MILLION)
TABLE 180. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY JOINT HEALTH, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 181. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SKIN HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 182. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SKIN HEALTH, BY GROUP, 2018-2030 (USD MILLION)
TABLE 183. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SKIN HEALTH, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 184. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SPORTS NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 185. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SPORTS NUTRITION, BY GROUP, 2018-2030 (USD MILLION)
TABLE 186. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SPORTS NUTRITION, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 187. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 188. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 189. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 190. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 191. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 192. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2030 (USD MILLION)
TABLE 193. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 194. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 195. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2030 (USD MILLION)
TABLE 196. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 197. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
TABLE 198. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY WOUND HEALING, BY GROUP, 2018-2030 (USD MILLION)
TABLE 199. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY WOUND HEALING, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 200. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 201. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 202. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 203. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 204. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 205. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY GROUP, 2018-2030 (USD MILLION)
TABLE 206. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 207. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 208. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 209. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 210. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 212. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2030 (USD MILLION)
TABLE 213. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 214. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 215. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2030 (USD MILLION)
TABLE 216. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 217. GLOBAL VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 218. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
TABLE 219. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AFFINITY LIGANDS & BINDING PROTEINS, 2018-2030 (USD MILLION)
TABLE 221. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CARRIER PROTEINS, 2018-2030 (USD MILLION)
TABLE 222. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONES & FOLDING AIDS, 2018-2030 (USD MILLION)
TABLE 223. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 224. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXTRACELLULAR MATRIX & COATINGS, 2018-2030 (USD MILLION)
TABLE 225. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, 2018-2030 (USD MILLION)
TABLE 226. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SERUM REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 227. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 228. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 230. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 231. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 232. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 233. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 234. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 235. AMERICAS VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 237. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AFFINITY LIGANDS & BINDING PROTEINS, 2018-2030 (USD MILLION)
TABLE 239. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CARRIER PROTEINS, 2018-2030 (USD MILLION)
TABLE 240. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONES & FOLDING AIDS, 2018-2030 (USD MILLION)
TABLE 241. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 242. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXTRACELLULAR MATRIX & COATINGS, 2018-2030 (USD MILLION)
TABLE 243. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, 2018-2030 (USD MILLION)
TABLE 244. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SERUM REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 245. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 246. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 247. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 248. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 249. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 250. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 251. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 252. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 253. NORTH AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 255. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 256. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY AFFINITY LIGANDS & BINDING PROTEINS, 2018-2030 (USD MILLION)
TABLE 257. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CARRIER PROTEINS, 2018-2030 (USD MILLION)
TABLE 258. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY CHAPERONES & FOLDING AIDS, 2018-2030 (USD MILLION)
TABLE 259. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 260. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY EXTRACELLULAR MATRIX & COATINGS, 2018-2030 (USD MILLION)
TABLE 261. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS & CYTOKINES, 2018-2030 (USD MILLION)
TABLE 262. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SERUM REPLACEMENTS, 2018-2030 (USD MILLION)
TABLE 263. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 264. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 265. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY ANIMAL NUTRITION, 2018-2030 (USD MILLION)
TABLE 266. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY COSMETICS, 2018-2030 (USD MILLION)
TABLE 267. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY MEDICAL DEVICES, 2018-2030 (USD MILLION)
TABLE 268. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY NUTRACEUTICALS, 2018-2030 (USD MILLION)
TABLE 269. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 270. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 271. LATIN AMERICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA VITAL PROTEINS FOR BIOMANUFACTURING MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
TABLE

Companies Mentioned

The key companies profiled in this Vital Proteins for Biomanufacturing market report include:
  • Abnova Corporation
  • Agilent Technologies, Inc.
  • Ashland Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioCell Technology, LLC
  • Bovine Collagen Products LLC.
  • Bristol-Myers Squibb Company
  • Creative BioMart Inc.
  • Croyez Bioscience Co., Ltd.
  • Danaher Corporation
  • Darling Ingredients Inc.
  • Enzo Life Sciences, Inc.
  • Evonik Industries AG
  • Gelita AG
  • GenScript Biotech Corporation
  • Holista Colltech Ltd.
  • Humabiologics, Inc
  • Lapi Gelatine S.p.A.
  • Lonza Group AG
  • Merck KGaA
  • Meridian Bioscience, Inc. by SD Biosensor Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • Nippi Collagen NA Inc.
  • Nitta Gelatin, Inc.
  • ProMab Biotechnologies, Inc.
  • Revvity, Inc.
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • Weishardt International

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 61.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 94.81 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

The Global Industrial Biomanufacturing Market 2026-2036 - Product Image

The Global Industrial Biomanufacturing Market 2026-2036

  • Report
  • 1316 Pages
  • Global
From
The Global Synthetic Biology & Biomanufacturing Market 2026-2036 - Product Image

The Global Synthetic Biology & Biomanufacturing Market 2026-2036

  • Report
  • 1135 Pages
  • Global
Next-Generation Biomanufacturing Market - Global Forecast 2026-2032 - Product Image

Next-Generation Biomanufacturing Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Digital Biomanufacturing Market - Global Forecast 2026-2032 - Product Image

Digital Biomanufacturing Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Digital Biomanufacturing Market - Global Strategic Business Report - Product Image

Digital Biomanufacturing Market - Global Strategic Business Report

  • Report
  • 341 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.